Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Sönnerborg

Showing results (1-10 of 241) with videos related to

Pageof 25
Sort By:
Lakartidningen|May 5, 2020
[Bats and humans]Anders Sönnerborg
Scandinavian Journal of Infectious Diseases. Supplementum|March 6, 2004
Use of genotypic assays for the detection of antiretroviral resistance: a legal proceeding, Rome, 22-23 April 2002Anders Sönnerborg
Lakartidningen|November 26, 2020
[Future testing for SARS-CoV-2: not only more but smarter]Emmi Andersson, Anders Sönnerborg
Lakartidningen|November 27, 2002
[Swedish guidelines for antiretroviral treatment of HIV. Good compliance is crucial for a good result]Magnus Gisslén, Anders Sönnerborg
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2006
Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapyOlle Karlström, Filip Josephson, Anders Sönnerborg
Lakartidningen|April 9, 2020
Hedvig Glans, Anders Sönnerborg, Soo Aleman
AIDS (London, England)|April 7, 2007
Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infectionPiotr Nowak, Babilonia Barqasho, Anders Sönnerborg
Current Opinion in HIV and AIDS|June 14, 2024
Elite controllers microbiome: unraveling the mystery of association and causationXiangning Bai, Anders Sönnerborg, Piotr Nowak
AIDS (London, England)|April 23, 2008
Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapyOlle Karlström, Anders Sönnerborg, Ola Weiland
Journal of Clinical Microbiology|October 2, 2002
Quantification of human immunodeficiency virus type 1 proviral DNA by the TaqMan real-time PCR assayZhibing Yun, Eva Fredriksson, Anders Sönnerborg
Pageof 25

Showing results (1-10 of 241) with videos related to

Sort By:
Pageof 25
Lakartidningen|May 5, 2020
[Bats and humans]Anders Sönnerborg
Scandinavian Journal of Infectious Diseases. Supplementum|March 6, 2004
Use of genotypic assays for the detection of antiretroviral resistance: a legal proceeding, Rome, 22-23 April 2002Anders Sönnerborg
Lakartidningen|November 26, 2020
[Future testing for SARS-CoV-2: not only more but smarter]Emmi Andersson, Anders Sönnerborg
Lakartidningen|November 27, 2002
[Swedish guidelines for antiretroviral treatment of HIV. Good compliance is crucial for a good result]Magnus Gisslén, Anders Sönnerborg
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2006
Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapyOlle Karlström, Filip Josephson, Anders Sönnerborg
Lakartidningen|April 9, 2020
Hedvig Glans, Anders Sönnerborg, Soo Aleman
AIDS (London, England)|April 7, 2007
Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infectionPiotr Nowak, Babilonia Barqasho, Anders Sönnerborg
Current Opinion in HIV and AIDS|June 14, 2024
Elite controllers microbiome: unraveling the mystery of association and causationXiangning Bai, Anders Sönnerborg, Piotr Nowak
AIDS (London, England)|April 23, 2008
Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapyOlle Karlström, Anders Sönnerborg, Ola Weiland
Journal of Clinical Microbiology|October 2, 2002
Quantification of human immunodeficiency virus type 1 proviral DNA by the TaqMan real-time PCR assayZhibing Yun, Eva Fredriksson, Anders Sönnerborg
Pageof 25